Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Research and Markets
DUBLIN, September 24, 2013 /PRNewswire/ --
Research and Markets
( http://www.researchandmarkets.com/research/xvj2zn/market_for_select) has announced the addition of the "Market for Select Cardiovascular Drugs in the GCC Region-2012-16" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The $7.6 bn Pharmaceutical industry in the GCC region is poised for major growth in the coming years. Increase in the international crude oil prices and exports of crude and petro products have transformed the GCC economy. The local governments are increasingly focusing on improving the health and living standards of the population. Contraints in local manufacturing capacity and thriving counterfeit drugs market pose a major challenge but improved regulatory mechanism, increase in private sector participation coupled with rising private and public sector outlay and spend on healthcare presents a promising future for the industry.
This report focuses on the market for select cardiovascular drugs in the GCC region. Various market drivers in terms of changing lifestyle and rising disease incidence among the population has led to higher consumption of cardiovascular drugs in the region. Sensing the latent market opportunity, global pharma majors such as Novartis, Abbott, AstraZeneca have set up operations in the GCC region through local joint venture and distribution.
In addition to market forecast to 2016, the report also provides interesting insights into key molecules used, top brands, drug prices, procurement process among government and retail institutions. The report will serve as an effective guide for the drug companies, distributors, hospitals and other stakeholders who wish to enter the GCC healthcare market. The report also has profiles of companies and distributors in the GCC region."
Key Topics Covered:
2. Report Coverage
3. Glossary of terms
4. Executive summary
5. Healthcare sector in GCC
6. Pharmaceutical market in GCC
7. Cardiovascular market for select drugs in GCC
8. Profiles of key domestic pharmaceutical manufacturers
9. Annexure - Drugs price details by country - 2012
List of Exhibits
- Global Pharma
- Jamjoom Pharma
- Julphar - Gulf Pharmaceutical Industries
- Kuwait Saudi Pharmaceutical Industries
- Merck & Co., Inc
- National Pharmaceutical Industries Co
- Neo Pharma
- Novartis International AG
- Oman Pharmaceutical Products Co. L.L.C
- Pfizer, Inc
- Sanofi S.A.
- Saudi Pharmaceutical Industries & Medical Appliances Corporation
- Tabuk Pharmaceuticals Manufacturing Company
For more information visit http://www.researchandmarkets.com/research/xvj2zn/market_for_select
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices
©2012 PR Newswire. All Rights Reserved.